학술논문

Ulcer Disease in the Excluded Segments after Roux-en-Y Gastric Bypass: a Current Review of the Literature
Document Type
Review Paper
Source
Obesity Surgery: The Journal of Metabolic Surgery and Allied Care. 31(3):1280-1289
Subject
Anti-inflammatory agents
Non-steroidal anti-inflammatory drugs
Roux-Y gastric bypass
Peptic ulcer perforation
Hemorrhage
Gastritis
Gastrostomy
Morbid obesity
Gastric remnant
Language
English
ISSN
0960-8923
1708-0428
Abstract
Ulcer disease in excluded segments after Roux-Y gastric bypass (RYGB) is rare but can evolve into a life-threatening situation. The excluded segments exhibit a different behavior from that of non-altered anatomy; perforated ulcers do not result in pneumoperitoneum or free fluid, and therefore must be met with a low threshold for surgical exploration. The anatomical changes after RYGB impede routine access to the remnant stomach and duodenum. There are various options to address bleeding or perforated ulcers. While oversewing and drainage preserves the anatomy and forgoes resection, remnant gastrectomy offers a definitive solution. The importance of traditional risk factors such as smoking or use of non-steroidal anti-inflammatory drugs is unclear. Eradication of Helicobacter pylori and secondary prophylaxis with proton-pump inhibitors is advisable, albeit in double-dose.